Lung Cancer Chemotherapy, New Treatment and Related Patents

ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)

Volume 12, 4 Issues, 2017

Download PDF Flyer

Recent Patents on Anti-Cancer Drug Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 35th of 254 in Pharmacology & Pharmacy
  • 46th of 211 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Khurshid Zaman
Bentham Science Publishers

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.533
5 - Year: 2.638

Lung Cancer Chemotherapy, New Treatment and Related Patents

Recent Patents on Anti-Cancer Drug Discovery, 9(3): 372-381.

Author(s): Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn.

Affiliation: 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road, Changklan Muang, Chiang Mai 50100, Thailand and 10th Office of Disease Prevention and Control, 447 Lumphun Road, Watgate Muang, Chiang Mai 50,000, Thailand.


The majority of patients with lung cancer present with advanced stage which contributes to death of more people than any other malignancy in the world. The discovery of a number of lung cancer-molecular alterations contributes to uniquely targeted therapies with specific inhibitors for non-small cell lung cancer such as erlotinib, gefitinib and crizotinib. Pemetrexed has statistically shown significantly reduced adverse side effects of drug compared with docetaxel. V1801, an analog of gefitinib may overcome gefitinib resistance in patients with non-small cell lung cancer. Thymosin α1, an immunomodulator significantly improves patient’s quality of life by enhancing T-cell function, stimulation of Tcell maturation and differentiation. Various novel compounds and chemotherapeutics were introduced in 2013 patents such as taxane, quinazoline, arylamino purine, benzodiazepine, pyrrolopyrimidine, nitrobenzamide, cyclopropane amide, 4-iodo-3-nitrobenzamide, heteroaryl (alkyl) dithiocarbamate, and histone deacetylase in treating non-small-cell lung cancer and piperidine, piperazine, picoplatin, and arsenic trioxide in treating small-cell lung cancer.


Cancer, chemotherapy, lung, lung cancer-molecular alterations, related patents, treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 372
Last Page: 381
Page Count: 10
DOI: 10.2174/1574892809666140520120806
Price: $100

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science